This article is more than 5 years old. Information may no longer be current.

Neuragain opens brain health and performance office in New York

Neuragain LLC recently announced the launch of its first physician office in New York City.

Amanda Itzkoff, MD, of Bespoke Manhattan Psychiatry and Mount Sinai School of Medicine, has added Neuragain’s treatments for depression, anxiety and other psychiatric disorders, including ketamine infusion therapy, to her existing practice.

“We are very pleased that Dr. Itzkoff recognizes the tremendous impact which Neuragain's treatments can have on the suffering of people with depression and other conditions,” Henrik Sandell, PhD, CEO of Neuragain, said in a press release. “Doctors around the country are seeing the benefits that a relationship with Neuragain can deliver to their patients and their practices.”